Location: San Francisco, CA
CIK: 0001056807 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 14, 2023
Total Value: $3.588B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 21,751,284 | $1.109B | 30.9% | — | — | CLASS A ORD | 61559X104 |
| RVMD | REVOLUTION MEDICINES INC | 6,255,588 | $167M | 4.7% | — | — | COM | 76155X100 |
| AXSM | AXSOME THERAPEUTICS INC | 2,131,100 | $153M | 4.3% | — | — | COM | 05464T104 |
| IDYA | IDEAYA BIOSCIENCES INC | 5,683,489 | $134M | 3.7% | — | — | COM | 45166A102 |
| IONS | IONIS PHARMACEUTICALS INC | 2,846,015 | $117M | 3.3% | — | — | COM | 462222100 |
| GHRS | GH RESEARCH PLC | 9,275,158 | $110M | 3.1% | — | — | ORDINARY SHARES | G3855L106 |
| KYMR | KYMERA THERAPEUTICS INC | 4,739,004 | $109M | 3.0% | — | — | COM | 501575104 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 3,775,900 | $104M | 2.9% | — | — | COM | 74366E102 |
| — | POINT BIOPHARMA GLOBAL INC | 10,563,748 | $95.71M | 2.7% | — | — | COM | 730541109 |
| GLPG | GALAPAGOS NV | 2,165,109 | $88.03M | 2.5% | — | — | SPON ADR | 36315X101 |
| — | REPARE THERAPEUTICS INC | 8,291,988 | $87.73M | 2.4% | — | — | COM | 760273102 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,750,000 | $72.75M | 2.0% | — | — | SPONSORED ADS | 86366E106 |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 4,007,413 | $72.41M | 2.0% | — | — | COM | 35104E100 |
| KURA | KURA ONCOLOGY INC | 6,730,983 | $71.21M | 2.0% | — | — | COM | 50127T109 |
| XENE | XENON PHARMACEUTICALS INC | 1,827,958 | $70.38M | 2.0% | — | — | COM | 98420N105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 7,611,503 | $68.73M | 1.9% | — | — | COM | 68062P106 |
| XOMA | XOMA CORP DEL | 3,633,743 | $68.64M | 1.9% | — | — | COM NEW | 98419J206 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 9,423,215 | $58.33M | 1.6% | — | — | SPONSORED ADS | 152309100 |
| ZYME | ZYMEWORKS INC | 5,870,000 | $50.72M | 1.4% | — | — | COM | 98985Y108 |
| REPL | REPLIMUNE GROUP INC | 2,143,036 | $49.76M | 1.4% | — | — | COM | 76029N106 |
| JANX | JANUX THERAPEUTICS INC | 4,106,945 | $48.75M | 1.4% | — | — | COM | 47103J105 |
| TYRA | TYRA BIOSCIENCES INC | 2,739,595 | $46.66M | 1.3% | — | — | COM | 90240B106 |
| LXRX | LEXICON PHARMACEUTICALS INC | 19,995,332 | $45.79M | 1.3% | — | — | COM NEW | 528872302 |
| — | MERUS N V | 1,602,420 | $42.19M | 1.2% | — | — | COM | N5749R100 |
| RLAY | RELAY THERAPEUTICS INC | 3,120,521 | $39.19M | 1.1% | — | — | COM | 75943R102 |
| — | ALLAKOS INC | 8,652,417 | $37.72M | 1.1% | — | — | COM | 01671P100 |
| — | 89BIO INC | 1,846,154 | $34.98M | 1.0% | — | — | COM | 282559103 |
| ACRS | ACLARIS THERAPEUTICS INC | 3,360,941 | $34.85M | 1.0% | — | — | COM | 00461U105 |
| CGEM | CULLINAN ONCOLOGY INC | 3,196,701 | $34.4M | 1.0% | — | — | COM | 230031106 |
| — | ITEOS THERAPEUTICS INC | 1,810,835 | $23.98M | 0.7% | — | — | COM | 46565G104 |
| — | ESSA PHARMA INC | 8,748,629 | $23.62M | 0.7% | — | — | COM NEW | 29668H708 |
| OVID | OVID THERAPEUTICS INC | 6,851,051 | $22.47M | 0.6% | — | — | COM | 690469101 |
| ACIU | AC IMMUNE SA | 7,428,379 | $21.95M | 0.6% | — | — | SHS | H00263105 |
| — | THIRD HARMONIC BIO INC | 4,365,933 | $21M | 0.6% | — | — | COM | 88427A107 |
| — | IKENA ONCOLOGY INC | 3,169,164 | $20.79M | 0.6% | — | — | COM | 45175G108 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 1,521,948 | $18.1M | 0.5% | — | — | ORDINARY SHARES | N62509109 |
| — | VIGIL NEUROSCIENCE INC | 1,813,633 | $17.05M | 0.5% | — | — | COM | 92673K108 |
| — | GLYCOMIMETICS INC | 9,544,262 | $16.61M | 0.5% | — | — | COM | 38000Q102 |
| — | SUTRO BIOPHARMA INC | 3,347,946 | $15.57M | 0.4% | — | — | COM | 869367102 |
| — | JASPER THERAPEUTICS INC | 9,900,000 | $13.56M | 0.4% | — | — | COM | 471871103 |
| ANTX | AN2 THERAPEUTICS INC | 1,563,963 | $13.29M | 0.4% | — | — | COM | 037326105 |
| VSTM | VERASTEM INC | 1,685,219 | $12.54M | 0.3% | — | — | COM NEW | 92337C203 |
| — | VERVE THERAPEUTICS INC | 650,000 | $12.19M | 0.3% | — | — | COM | 92539P101 |
| — | CALLIDITAS THERAPEUTICS AB | 750,000 | $11.78M | 0.3% | — | — | SPONSERED ADS | 13124Q106 |
| CTMX | CYTOMX THERAPEUTICS INC | 6,595,801 | $11.34M | 0.3% | — | — | COM | 23284F105 |
| SLN | SILENCE THERAPEUTICS PLC | 1,508,416 | $8.296M | 0.2% | — | — | ADS | 82686Q101 |
| — | CIDARA THERAPEUTICS INC | 6,861,127 | $7.753M | 0.2% | — | — | COM | 171757107 |
| TCRX | TSCAN THERAPEUTICS INC | 2,989,474 | $7.474M | 0.2% | — | — | COM | 89854M101 |
| DCTH | DELCATH SYS INC | 1,178,787 | $6.872M | 0.2% | — | — | COM NEW | 24661P807 |
| — | NLS PHARMACEUTICS LTD | 5,747,126 | $6.322M | 0.2% | — | — | SHS | H57830103 |
| — | ARAVIVE INC | 4,784,214 | $6.028M | 0.2% | — | — | COM | 03890D108 |
| ELDN | ELEDON PHARMACEUTICALS INC | 4,326,710 | $5.928M | 0.2% | — | — | COM | 28617K101 |
| — | VIRACTA THERAPEUTICS INC | 3,614,662 | $5.097M | 0.1% | — | — | COM | 92765F108 |
| — | KRONOS BIO INC | 2,813,485 | $4.839M | 0.1% | — | — | COM | 50107A104 |
| — | RAIN ONCOLOGY INC | 3,526,729 | $4.232M | 0.1% | — | — | COM | 75082Q105 |
| — | ASLAN PHARMACEUTICALS LTD | 1,049,999 | $3.832M | 0.1% | — | — | SPON ADS NEW | 04522R200 |
| — | ELEVATION ONCOLOGY INC | 2,312,200 | $3.515M | 0.1% | — | — | COM | 28623U101 |
| — | PIERIS PHARMACEUTICALS INC | 20,609,863 | $3.411M | 0.1% | — | — | COM | 720795103 |
| CRVS | CORVUS PHARMACEUTICALS INC | 1,370,947 | $3.139M | 0.1% | — | — | COM | 221015100 |
| IMUX | IMMUNIC INC | 1,149,425 | $2.885M | 0.1% | — | — | COM | 4525EP101 |
| IVA | INVENTIVA SA | 686,040 | $2.772M | 0.1% | — | — | ADS | 46124U107 |
| MOLN | MOLECULAR PARTNERS AG | 443,221 | $2.708M | 0.1% | — | — | ADS | 60853G106 |
| — | MOLECULAR TEMPLATES INC | 4,996,565 | $2.398M | 0.1% | — | — | COM | 608550109 |
| INFIQ | INFINITY PHARMACEUTICALS INC | 6,353,645 | $1.337M | 0.0% | — | — | COM | 45665G303 |
| RZLT | REZOLUTE INC | 190,815 | $378K | 0.0% | — | — | COM NEW | 76200L309 |
| — | GALMED PHARMACEUTICALS LTD | 89,853 | $261K | 0.0% | — | — | SHS NEW | M47238122 |
| — | BIONOMICS LIMITED | 80,971 | $178K | 0.0% | — | — | ADS | 09063M205 |